fenoldopam has been researched along with Metastase in 1 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The latency period of metastasis was estimated to be 12 days after tumor implantation." | 1.91 | Application of a count data model to evaluate the anti-metastatic efficacy of QAP14 in 4T1 breast cancer allografts. ( Guo, Y; Han, M; Jian, W; Xue, J; Yao, Q; Yong, L; Zhou, T, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y | 1 |
| Yong, L | 1 |
| Yao, Q | 1 |
| Han, M | 1 |
| Xue, J | 1 |
| Jian, W | 1 |
| Zhou, T | 1 |
1 other study available for fenoldopam and Metastase
| Article | Year |
|---|---|
Application of a count data model to evaluate the anti-metastatic efficacy of QAP14 in 4T1 breast cancer allografts.
Topics: Allografts; Animals; Cell Line, Tumor; Fenoldopam; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neopla | 2023 |